Neuphoria Therapeutics Inc. - Common Stock, par value $0.00001 per share (NEUP) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
NEUP on Nasdaq
Shares outstanding
5,370,110
Price per share
$3.85
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
195,338
Total reported value
$2,303,036
% of total 13F portfolios
0%
Share change
+17,375
Value change
+$535,083
Number of holders
15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Neuphoria Therapeutics Inc. - Common Stock, par value $0.00001 per share (NEUP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 5% $5,365,401 1,033,796 Armistice Capital, LLC 31 Dec 2024
Lynx1 Capital Management LP 16% 0% $3,877,703 875,328 0% Lynx1 Capital Management LP 26 Dec 2025
Baselake Partners, LP 9.4% $2,635,553 222,222 Baselake Partners, LP 27 Oct 2025
Shay Capital LLC 7.3% $2,035,520 171,629 Shay Capital LLC 24 Oct 2025
Coastlands Capital LP 5.1% $1,423,200 120,000 Coastlands Capital LP 05 Nov 2025
Apeiron Investment Group Ltd. 4.5% $376,887 72,618 Apeiron Investment Group Ltd. 24 Jan 2025

As of 30 Sep 2025, 15 institutional investors reported holding 195,338 shares of Neuphoria Therapeutics Inc. - Common Stock, par value $0.00001 per share (NEUP). This represents 3.6% of the company’s total 5,370,110 outstanding shares.

Institutional Holders of Neuphoria Therapeutics Inc. - Common Stock, par value $0.00001 per share (NEUP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 26,500 $102,000 +$102,000 $3.85 1
2025 Q3 195,338 $2,303,036 +$535,083 $11.79 15
2025 Q2 177,963 $1,263,538 +$105,431 $7.10 9
2025 Q1 163,114 $935,356 +$529,238 $5.76 7
2024 Q4 79,719 $273,435 +$239,042 $3.43 7